| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±5.2% | +0.9% | over-priced |
| 05/06/2026 | ±3.8% | +3.1% | over-priced |
| 02/27/2026 | ±3.6% | +0.5% | over-priced |
| 11/05/2025 | ±5.6% | +1.1% | over-priced |
| 08/06/2025 | ±14.6% | -2.0% | over-priced |
| 05/08/2025 | ±5.3% | +5.1% | over-priced |
| 02/28/2025 | ±4.7% | +0.7% | over-priced |
| 11/05/2024 | ±3.5% | +0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.51 | $1.1B | $108M |
| Q1 FY2026 | $1.57 | $1.0B | $113M |
| Q4 FY2025 | — | $1.0B | $136M |
| Q3 FY2025 | $0.78 | $996M | $57M |
Align Technology, Inc. Common Stock (ALGN) reports in 7 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±5.8% earnings move while the stock actually moved 1.8% on average — the market has systematically over-priced ALGN's earnings risk. Fundamentals into the print: EPS down 12.2% year-over-year, revenue up 4.3%. QuantLogix's live 5-factor engine currently reads ALGN as a underweight at 40/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →